Intranasal vaccination
Vaginal Memory T Cells Induced by Intranasal Vaccination Are Critical for Protective T Cell Recruitment and Prevention of Genital HSV-2 Disease
10
Intranasal Vaccination with Chitosan-DNA Nanoparticles Expressing Pneumococcal Surface Antigen A Protects Mice against Nasopharyngeal Colonization by Streptococcus pneumoniae
7
Intranasal Vaccination with Recombinant Adeno-Associated Virus Type 5 against Human Papillomavirus Type 16 L1
10
Ocular Immune Responses in Steers following Intranasal Vaccination with Recombinant Moraxella bovis Cytotoxin Adjuvanted with Polyacrylic Acid
7
Intranasal vaccination with extracellular serine proteases of Leishmania amazonensis confers protective immunity to BALB/c mice against infection
7
SARS CORONAVIRUS: AN OVERVIEW
10
Responses of primary human nasal epithelial cells to EDIII DENV stimulation: the first step to intranasal dengue vaccination
8
SARS CORONAVIRUS: AN OVERVIEW
10
Enhancement of Serum and Mucosal Immune Responses to a Haemophilus influenzae Type B Vaccine by Intranasal Delivery
7
AuNP-M2e + sCpG vaccination of juvenile mice generates lifelong protective immunity to influenza A virus infection
12
Dose Response of Attenuated Bordetella pertussis BPZE1-Induced Protection in Mice
8
Case of Advanced Recurrent Glioblastoma Successfully Treated with Monoterpene Perillyl Alcohol by Intranasal Administration
6
Randomised, crossover clinical trial, in healthy volunteers, to compare the systemic availability of two topical intranasal budesonide formulations
7
The analgesic effect of combined treatment with intranasal S-ketamine and intranasal midazolam compared with morphine patient-controlled analgesia in spinal surgery patients: a pilot study
8
A Comparative Evaluation of Intranasal Dexmedetomidine and Intranasal Midazolam for Premedication in Children
9
NANOCARRIER FOR INTRANASAL ADMINISTRATION
6
Intranasal administration of poly gamma glutamate induced antiviral activity and protective immune responses against H1N1 influenza A virus infection
10
Aerosolized adenovirus-vectored vaccine as an alternative vaccine delivery method
7
Intranasal administration of cationic liposomes enhanced granulocyte–macrophage colony stimulating factor expression and this expression is dispensable for mucosal adjuvant activity
8
Development and evaluation of thymoquinone-encapsulated chitosan nanoparticles for nose-to-brain targeting: a pharmacoscintigraphic study
14